Gala vs Telos Rx: Compounded GLP-1 pricing, shipping and care compared
Gala vs Telos Rx quickly: both are direct-pay telehealth options offering compounded semaglutide and tirzepatide with clinician review. Early verdict: choose Gala if you want an advertised flat all-inclusive price with free two-day shipping and a $220 promotion; choose Telos Rx if you prioritize an advertised lower starting price for semaglutide as low as $99 per month, subject to provider approval and plan details.
How they compare on pricing and promotions
Price presentation is a key difference in this Gala vs Telos Rx comparison. Gala advertises a flat all-inclusive price covering provider visit, medication, shipping and ongoing care and promotes a $220 discount. The captured Gala page also shows “compounded semaglutide from $249/mo” in headline text but the base dollar price was not visible in readable page text. Telos Rx publishes explicit monthly starting points on the captured page: semaglutide from $99 per month and tirzepatide from $139 per month, with statements like “as low as $99 per month” and “Pay $0 if not approved.” Both providers note prices depend on plan and medical approval where applicable.
Direct comparison table
| Criteria | Gala | Telos Rx |
|---|---|---|
| Medications offered | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide |
| Starting price (captured) | Page advertises $220 off; base price not exposed in readable text | Semaglutide from $99 per month; tirzepatide from $139 per month |
| Price structure | Flat all-inclusive price covering visit, medication, shipping and ongoing care | As low as pricing per month; your price depends on plan |
| Shipping | Free two-day shipping claimed | Shipping details not verified on captured page |
| Clinical review | Provider visit and prescription included; treatment available only when a licensed clinician determines it is medically appropriate | Prescribed online after review by a US-licensed provider; subject to medical approval |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Care model and inclusions compared
Both providers operate as telehealth platforms and require clinician review before prescribing. Gala emphasizes a single flat price that it says includes the provider visit, prescription, ongoing care and shipping. The Gala landing capture notes “Provider visit & prescription included” and recurring claims such as “No Monthly Membership” and “Cancel Anytime.” Telos Rx emphasizes clinician-reviewed prescriptions and matches molecule choice to the patient, describing semaglutide as acting on GLP-1 and tirzepatide as acting on GLP-1 plus GIP. Telos Rx also communicates that pricing and plan details can affect your monthly cost and that treatment is subject to clinician review.
Check Telos Rx starting prices
Transparency and marketing language
Gala uses promotional language on its landing page including a $220 promotion, frequent repetition of outcome-style statements on the captured text and claims of “one flat price at every dose” and “no hidden fees.” The source also repeats testimonial-style weight examples in the captured text. Telos Rx provides explicit monthly ranges on the captured page and includes qualifying language such as “if a licensed provider approves you” and “Your price depends on your plan.” Both pages include the important regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Distinctive supported differences
- Price presentation: Gala promotes a flat all-inclusive price with a $220 promotion while Telos Rx lists semaglutide as low as $99 per month in captured pricing.
- Shipping claim: Gala advertises free two-day shipping on the captured page; Telos Rx captured evidence did not verify shipping terms.
- Detail visibility: Telos Rx shows explicit monthly starting figures in the capture; Gala’s captured content did not expose a clear base dollar monthly price in readable text despite promotional claims.
View Gala payment and shipping details
Safety and regulatory reminders
Both captured sources clearly state that semaglutide and tirzepatide when offered as compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both require review and prescription from a licensed clinician and note that treatment is available only when a clinician determines it is medically appropriate. Individual results vary and are not guaranteed according to the captured Telos Rx copy.
Confirm Gala eligibility and clinician review
Bottom line and how to choose
In summary of Gala vs Telos Rx: Gala is presented as a flat all-inclusive direct-pay option with a claimed $220 promotion and free two-day shipping, but the captured page did not expose a clear base price in readable text. Telos Rx presents explicit starting monthly prices in the captured content, with semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” both subject to clinician approval and plan details. Both require clinician review and both note that compounded medications are not FDA-approved.
Choose Gala if you want an advertised flat all-inclusive price that the provider says covers the visit, medication, shipping and ongoing care and if the $220 promotion and free two-day shipping are priorities. Choose Telos Rx if the captured starting price of semaglutide as low as $99 per month or transparent per-month starting figures matter most to you and you accept that final pricing is subject to clinician approval and your plan.
For either option, confirm eligibility, medication details, renewal terms and state availability before enrollment.